Taysha Gene Therapies Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 08/14/2026 | 23.89 M | $162.68 M | 10.09% | 6.47% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 23.56 M | $160.41 M | 0.00% | 6.38% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 22.71 M | $154.68 M | 1.54% | 6.15% |
| BLACKROCK, INC. | 08/07/2026 | 20.69 M | $140.91 M | 12.67% | 5.61% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 19.42 M | $132.22 M | 7.86% | 5.26% |
| MORGAN STANLEY | 08/13/2026 | 16.49 M | $112.28 M | -8.23% | 4.47% |
| RTW INVESTMENTS, LP | 08/14/2026 | 13.56 M | $92.35 M | -0.88% | 3.67% |
| FMR LLC | 08/13/2026 | 13.34 M | $90.82 M | -6.88% | 3.61% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 12.48 M | $84.98 M | 21.96% | 3.38% |
| STATE STREET CORP | 08/07/2026 | 11.42 M | $77.78 M | 1.90% | 3.10% |
| SIREN, L.L.C. | 08/13/2026 | 9.85 M | $67.06 M | 11.51% | 2.67% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2026 | 9.69 M | $66.01 M | 9.41% | 2.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 6.56 M | $44.69 M | 18.59% | 1.78% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 5.12 M | $34.85 M | -9.50% | 1.39% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 4.50 M | $30.65 M | 100.00% | 1.22% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 4.40 M | $29.95 M | -0.65% | 1.19% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 4.00 M | $27.27 M | 0.00% | 1.09% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 3.98 M | $27.07 M | 534.71% | 1.08% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 08/13/2026 | 3.89 M | $26.46 M | 34.76% | 1.05% |
| CASDIN CAPITAL, LLC | 08/14/2026 | 3.25 M | $22.13 M | 0.00% | 0.88% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 3.14 M | $21.38 M | 55.25% | 0.85% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 3.04 M | $20.71 M | 2.05% | 0.82% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 2.77 M | $18.87 M | 14,242.59% | 0.75% |
| ABRDN PLC | 07/31/2026 | 2.33 M | $15.85 M | 127.91% | 0.63% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2026 | 2.25 M | $15.32 M | 100.00% | 0.61% |
| NORGES BANK | 08/12/2026 | 2.23 M | $15.21 M | 100.00% | 0.61% |
| NORTHERN TRUST CORP | 08/13/2026 | 2.23 M | $15.16 M | 22.70% | 0.60% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 2.20 M | $14.99 M | 21.68% | 0.60% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 2.20 M | $14.99 M | 100.00% | 0.60% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.13 M | $14.48 M | -35.19% | 0.58% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 2.00 M | $13.62 M | 100.00% | 0.54% |
| RICE HALL JAMES & ASSOCIATES, LLC | 08/07/2026 | 1.99 M | $13.57 M | 2.45% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.90 M | $12.91 M | 23.92% | 0.51% |
| B GROUP, INC. | 08/14/2026 | 1.80 M | $12.26 M | 0.00% | 0.49% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 1.75 M | $11.92 M | 75.00% | 0.47% |
| BARCLAYS PLC | 08/14/2026 | 1.63 M | $11.10 M | -42.01% | 0.44% |
| CITADEL ADVISORS LLC | 09/02/2026 | 1.54 M | $10.46 M | 273.43% | 0.42% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 1.50 M | $9.94 M | 140.43% | 0.41% |
| HEIGHTS CAPITAL MANAGEMENT, INC | 08/14/2026 | 1.50 M | $10.22 M | 100.00% | 0.41% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 1.39 M | $9.48 M | 0.00% | 0.38% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.37 M | $9.35 M | -18.14% | 0.37% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 1.31 M | $8.89 M | 47.77% | 0.35% |
| QUANTUM PRIVATE WEALTH, LLC | 07/29/2026 | 812.03 K | $5.53 M | -4.38% | 0.22% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 791.17 K | $5.39 M | 100.00% | 0.21% |
| JPMORGAN CHASE & CO | 08/12/2026 | 766.28 K | $5.16 M | 1.52% | 0.21% |
| SANDS CAPITAL VENTURES, LLC | 08/13/2026 | 724.87 K | $4.94 M | 0.00% | 0.20% |
| GORDONMD GLOBAL INVESTMENTS LP | 08/14/2026 | 723.19 K | $24.50 M | -1.95% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 697.97 K | $4.75 M | 14.77% | 0.19% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 640.04 K | $4.36 M | 432.48% | 0.17% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 590.39 K | $4.02 M | 224.10% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Taysha Gene Therapies Inc institutional Ownership - FAQ's
During the previous two years, 252 institutional investors and hedge funds held shares of Taysha Gene Therapies Inc. The most heavily invested institutionals were:
Avoro Capital Advisors LLC: 23.89 M
RA CAPITAL MANAGEMENT, L.P.: 23.56 M
GOLDMAN SACHS GROUP INC: 22.71 M
BlackRock, Inc.: 20.69 M
Vestal Point Capital, LP: 19.42 M
MORGAN STANLEY: 16.49 M
81.77% of Taysha Gene Therapies Inc stock is owned by institutional investors.
Institutional investors have bought a total of 333.77 M shares in the last 24 months. This purchase volume represents approximately $1.53 B in transactions.